Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11479608 Anti-CTLA4 antibodies

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Peng Zhang0

Zhongmin Wang0

Yu Xia0

Xinghua Pang0

Baiyong Li0

Date of Patent

October 25, 2022

0

Patent Application Number

163276150

Date Filed

August 21, 2017

0

Patent Citations

US Patent 10066013 Anti-PD-1 antibody and use thereof

US Patent 10072082 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling

0

US Patent 10030064 Mammalian cell culture processes for protein production

0

Patent Primary Examiner

Bridget E Bunner

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention belongs to the fields of tumor therapy and molecular immunology. The present invention relates to an anti-CTLA4 antibody, pharmaceutical composition and use thereof. The anti-CTLA4 antibody of the present invention can specifically bind CTLA4, and can very effectively block the binding of CLTA4 to B7.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11479608 Anti-CTLA4 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.